Anti-GPX4/ GPx-4/ GSHPx-4 functional antibody
Anti-GPX4/ GPx-4/ GSHPx-4 functional antibody for cell culture, ELISA & in-vivo assay
Go to GPX4/GPX4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE1581-Ab-1/ GM-Tg-hg-SE1581-Ab-2 | Anti-Human GPX4 monoclonal antibody | Human |
GM-Tg-rg-SE1581-Ab-1/ GM-Tg-rg-SE1581-Ab-2 | Anti-Rat GPX4 monoclonal antibody | Rat |
GM-Tg-mg-SE1581-Ab-1/ GM-Tg-mg-SE1581-Ab-2 | Anti-Mouse GPX4 monoclonal antibody | Mouse |
GM-Tg-cynog-SE1581-Ab-1/ GM-Tg-cynog-SE1581-Ab-2 | Anti-Cynomolgus/ Rhesus macaque GPX4 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE1581-Ab-1/ GM-Tg-felg-SE1581-Ab-2 | Anti-Feline GPX4 monoclonal antibody | Feline |
GM-Tg-cang-SE1581-Ab-1/ GM-Tg-cang-SE1581-Ab-2 | Anti-Canine GPX4 monoclonal antibody | Canine |
GM-Tg-bovg-SE1581-Ab-1/ GM-Tg-bovg-SE1581-Ab-2 | Anti-Bovine GPX4 monoclonal antibody | Bovine |
GM-Tg-equg-SE1581-Ab-1/ GM-Tg-equg-SE1581-Ab-2 | Anti-Equine GPX4 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE1581-Ab-1/ GM-Tg-hg-SE1581-Ab-2; GM-Tg-rg-SE1581-Ab-1/ GM-Tg-rg-SE1581-Ab-2; GM-Tg-mg-SE1581-Ab-1/ GM-Tg-mg-SE1581-Ab-2; GM-Tg-cynog-SE1581-Ab-1/ GM-Tg-cynog-SE1581-Ab-2; GM-Tg-felg-SE1581-Ab-1/ GM-Tg-felg-SE1581-Ab-2; GM-Tg-cang-SE1581-Ab-1/ GM-Tg-cang-SE1581-Ab-2; GM-Tg-bovg-SE1581-Ab-1/ GM-Tg-bovg-SE1581-Ab-2; GM-Tg-equg-SE1581-Ab-1/ GM-Tg-equg-SE1581-Ab-2 |
Products Name | Anti-GPX4 monoclonal antibody |
Format | mab |
Target Name | GPX4 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-GPX4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE1581-Ag-1 | Recombinant multi-species GPX4/ GPx-4/ GSHPx-4 protein |
ORF Viral Vector | pGMLP003326 | human GPX4 Lentivirus plasmid |
ORF Viral Vector | vGMLP003326 | human GPX4 Lentivirus particle |
ORF Viral Vector | pGMLPm000984 | mouse Gpx4 Lentivirus plasmid |
ORF Viral Vector | vGMLPm000984 | mouse Gpx4 Lentivirus particle |
Target information
Target ID | GM-SE1581 |
Target Name | GPX4 |
Gene ID | 2879,625249,29328,705333,119864793,101095956,286809,102147383 |
Gene Symbol and Synonyms | GPx-4,GPX4,GSHPx-4,MCSP,mtPHGPx,PHGPx,SMDS,snGPx,snPHGPx |
Uniprot Accession | P36969,P36970,Q9N2J2 |
Uniprot Entry Name | GPX4_HUMAN,GPX4_RAT,GPX4_BOVIN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000167468 |
Target Classification | N/A |
The target: GPX4, gene name: GPX4, also named as GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx, snPHGPx. The protein encoded by this gene belongs to the glutathione peroxidase family, members of which catalyze the reduction of hydrogen peroxide, organic hydroperoxides and lipid hydroperoxides, and thereby protect cells against oxidative damage. Several isozymes of this gene family exist in vertebrates, which vary in cellular location and substrate specificity. This isozyme has a high preference for lipid hydroperoxides and protects cells against membrane lipid peroxidation and cell death. It is also required for normal sperm development; thus, it has been identified as a 'moonlighting' protein because of its ability to serve dual functions as a peroxidase, as well as a structural protein in mature spermatozoa. Mutations in this gene are associated with Sedaghatian type of spondylometaphyseal dysplasia (SMDS). This isozyme is also a selenoprotein, containing the rare amino acid selenocysteine (Sec) at its active site. Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. Transcript variants resulting from alternative splicing or use of alternate promoters have been described to encode isoforms with different subcellular localization. [provided by RefSeq, Dec 2018].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.